ADVANCE CAPACITY: New Medication May Help Pulmonary Hypertension Patients Exercise Request More Information Trial Objective A clinical trial called ADVANCE CAPACITY seeks to understand if an investigational medication called ralinepag will help people with pulmonary arterial hypertension (PAH) improve their ability to exercise. Participants will be randomly assigned ralinepag or a placebo, an inactive substance that looks like the investigational medication. During clinic visits, participants may be given a physical exam, provide a blood sample, complete a questionnaire, and/or receive an electrocardiogram, or EKG. Participants' ability to exercise will be assessed using a stationary bike. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Patients diagnosed with pulmonary arterial hypertension Age: 18+ Gender: Any Gender Estimated Time Commitment Up to 8 visits over 28 weeks × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Provided Travel Reimbursement: Available Trial Contact For more information, contact: Jennifer Underwood 303.398.1518 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors United Therapeutics Principal Investigators Marjorie Patricia George, MD + × Marjorie Patricia George, MD Associate Professor Director, Pulmonary Hypertension Program Division of Pulmonary, Critical Care & Sleep Medicine Department of Medicine View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Co-Investigators Andrew Freeman, MD, FACC, FACP + × Andrew Freeman, MD, FACC, FACP Associate Professor Director of Cardiovascular Prevention and Wellness Director, Clinical Cardiology & Operations Director, Anticoagulation Clinic Division of Cardiology Department of Medicine View Full Profile Patient Rating 4.7 out of 5 stars Make an Appoinment Darlene Kim, MD, FACC + × Darlene Kim, MD, FACC Associate Professor Department of Medicine Division of Cardiology View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Mohammad Dalabih, MD + × Mohammad Dalabih, MD Assistant Professor Division of Pulmonary, Critical Care & Sleep Medicine Department of Medicine View Full Profile Make an Appoinment Vera Pillitteri, DNP, FNP-BC + × Vera Pillitteri, DNP, FNP-BC Family Nurse Practitioner Division of Cardiology Department of Medicine View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Request More Information By completing this form, you agree to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:* I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: YesNo
Trial Objective A clinical trial called ADVANCE CAPACITY seeks to understand if an investigational medication called ralinepag will help people with pulmonary arterial hypertension (PAH) improve their ability to exercise. Participants will be randomly assigned ralinepag or a placebo, an inactive substance that looks like the investigational medication. During clinic visits, participants may be given a physical exam, provide a blood sample, complete a questionnaire, and/or receive an electrocardiogram, or EKG. Participants' ability to exercise will be assessed using a stationary bike.